Cellomatics Biosciences provides specialist inflammation assays for pharmaceutical and biotechnology teams investigating inflammatory pathways, immune responses, and potential therapeutic candidates. Its expert scientific team uses relevant cell-based models. This helps to assess how compounds influence inflammatory activity under controllable laboratory conditions. These studies can support drug discovery programmes by generating useful data on cellular responses, biomarker production, and treatment effects.

By working with Cellomatics Biosciences, research organisations can access dedicated laboratory expertise without developing every assay capability internally. The company can support assay development, optimisation, and experimental testing according to individual project requirements. Its inflammation assays offer a practical research option for teams studying inflammatory diseases and evaluating new treatments. Cellomatics Biosciences’ established scientific experience helps clients obtain focused laboratory support for preclinical and translational research programmes.